We are live on ! Find out more
FOLD

Amicus Therapeutics
FOLD

Delisted

FOLD was delisted on the 24th of April, 2026.

Back to rankings

237 hedge funds and large institutions have $2.8B invested in Amicus Therapeutics in 2021 Q3 according to their latest regulatory filings, with 31 funds opening new positions, 82 increasing their positions, 77 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more call options, than puts

Call options by funds: $19.9M | Put options by funds: $13.2M

19% more first-time investments, than exits

New positions opened: 31 | Existing positions closed: 26

5.78% more ownership

Funds ownership: 104.09% → 109.87% (+5.8%)

6% more repeat investments, than reductions

Existing positions increased: 82 | Existing positions reduced: 77

5% more capital invested

Capital invested by funds: $2.67B → $2.8B (+$130M)

1% more funds holding

Funds holding: 235 → 237 (+2)

14% less funds holding in top 10

Funds holding in top 10: 7 → 6 (-1)

Holders
237
Holders Change
+2
Holders Change %
+0.85%
% of All Funds
4.15%
Holding in Top 10
6
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-14.29%
% of All Funds
0.11%
New
31
Increased
82
Reduced
77
Closed
26
Calls
$19.9M
Puts
$13.2M
Net Calls
+$6.65M
Net Calls Change
-$6.58M

Top Buyers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
+$88.2M
2
ACA
Avoro Capital Advisors
New York
+$53.5M
3
PA
Perceptive Advisors
New York
+$35.2M
4
AG
Artal Group
Luxembourg
+$30.1M
5
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$21.1M

Top Sellers

Rank Fund Capital Flow
1
Point72 Asset Management
Point72 Asset Management
Connecticut
-$37.3M
2
DM
Deerfield Management
New York
-$28.4M
3
GPP
Great Point Partners
Connecticut
-$13.8M
4
Deutsche Bank
Deutsche Bank
Germany
-$12.6M
5
Norges Bank
Norges Bank
Norway
-$11.2M
Name Holding Trade Value Shares
Change 		Change in
Stake
Susquehanna International Group
76
Susquehanna International Group
Pennsylvania
$3M +$963K +94,187 +43%
Citigroup
77
Citigroup
New York
$3M -$1.96M -191,924 -38%
Rafferty Asset Management
78
Rafferty Asset Management
New York
$2.91M +$603K +58,924 +24%
PPA
79
Parametric Portfolio Associates
Washington
$2.9M -$164K -15,991 -5%
UBS AM
80
UBS AM
Illinois
$2.73M -$401K -39,196 -12%
LC
81
Longitude (Cayman)
Cayman Islands
$2.72M +$297K +29,000 +11%
GTC
82
Ghost Tree Capital
New York
$2.53M – – –
State of New Jersey Common Pension Fund D
83
State of New Jersey Common Pension Fund D
New Jersey
$2.46M -$115K -11,214 -4%
Ameriprise
84
Ameriprise
Minnesota
$2.46M +$534K +52,237 +25%
Hudson Bay Capital Management
85
Hudson Bay Capital Management
Connecticut
$2.39M -$665K -65,000 -21%
GPP
86
Great Point Partners
Connecticut
$2.38M -$13.8M -1,351,000 -84%
CS
87
Credit Suisse
Switzerland
$2.34M -$223K -21,758 -8%
Millennium Management
88
Millennium Management
New York
$2.26M +$1.94M +190,124 +406%
Prudential Financial
89
Prudential Financial
New Jersey
$2.11M -$86.9K -8,493 -4%
Legal & General Group
90
Legal & General Group
United Kingdom
$1.98M +$424K +41,452 +25%
SBH
91
Segall Bryant & Hamill
Illinois
$1.9M +$54.2K +5,300 +3%
ECM
92
ExodusPoint Capital Management
New York
$1.89M +$1.12M +109,376 +124%
MOACM
93
Mutual of America Capital Management
New York
$1.87M -$29K -2,831 -1%
DnB Asset Management
94
DnB Asset Management
Norway
$1.67M +$1.53M +149,898 +615%
Invesco
95
Invesco
Georgia
$1.62M +$209K +20,439 +14%
GC
96
Guggenheim Capital
Illinois
$1.6M -$145K -14,183 -8%
HF
97
HRT Financial
New York
$1.54M +$1.65M +161,594 New
Royal Bank of Canada
98
Royal Bank of Canada
Ontario, Canada
$1.51M +$119K +11,657 +8%
TCA
99
Transcend Capital Advisors
New Jersey
$1.48M +$18.4K +1,800 +1%
AIG
100
American International Group
New York
$1.38M -$35K -3,421 -2%
2 3
4
5 6

FOLD Hedge Fund Activity: Q3 2021 in Review

237 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in Amicus Therapeutics (FOLD) for Q3 2021, worth a combined $2.8B — up 4.9% from $2.67B a quarter earlier.

Buyers outnumbered sellers: 31 funds opened new FOLD positions and 26 closed out — a net gain of 5 holders — while 82 added to existing stakes and 77 trimmed.

The largest buyer was Wellington Management Group, adding an estimated $88.2M. The largest seller was Point72 Asset Management, exiting entirely with an estimated $37.3M sold.

  • 237 institutional investors held Amicus Therapeutics (FOLD) as of Q3 2021, up from 235 in Q2 2021.
  • Funds reported $2.8B of Amicus Therapeutics stock for Q3 2021, up 4.9% quarter-over-quarter.
  • 31 funds opened new Amicus Therapeutics positions in Q3 2021 and 26 closed out, a net change of +5 holders.
  • The largest Amicus Therapeutics buyer in Q3 2021 was Wellington Management Group, an estimated $88.2M added.
  • The largest Amicus Therapeutics seller in Q3 2021 was Point72 Asset Management, an estimated $37.3M sold.

Based on aggregated 13F filings for Q3 2021.